GLP-1-A26-2 Amycretin and retatrutide to be tested for compatibility with DehydraTECH KELOWNA, BC / ACCESS Newswire / April 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference ...

South Korea's Penetrium Bioscience unveiled a novel approach to cancer treatment that targets the environments surrounding ...

Niagen Bioscience CEO Rob Fried explains nicotinamide riboside (NR), energy, and new at-home injections, IVs, and NAD+ ...

On December 2, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations, of which NH Life Sciences is a member, released a new report, “The U.S. Bioscience ...

The University of Florida's Whitney Lab opened a new $41.2 million marine research center, expanding its efforts.

A spin-out from the University of Oxford focused on climate-resilient crops is scaling its operations at Milton Park business campus following a £45m Series A raise.

Twist Bioscience shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...

After striking out in the pandemic phase of COVID-19 with its belated vaccine, Novavax seeks to recover in the endemic phase. And a big part of the company's plan centers around enhancing its ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.

Amycretin and retatrutide to be tested for compatibility with DehydraTECH KELOWNA, BC / ACCESS Newswire / April 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ...